Tachyon Ventures

EARLY-STAGE LIFE SCIENCES VENTURE CAPITAL

[Janice Chen @janiceschen]

Congrats to the @mammothbiosci team for entering NIH #RADx Phase II, which supports the scale-up of our #CRISPR SARS-CoV-2 #DETECTR assay onto high-throughput automation platforms in commercial labs. We are excited to partner with @NIH to help increase #COVID testing in the US!

[Tachyon Ventures @tachyon_vc]

Very nice study by @tarabiosystems and @Amgen showing the power of TARA’s human-based cardiac tissue platform in evaluating the safety and efficacy of new therapies early on in the discovery process: https://t.co/gRUMlUgeYm